METHOD

A method for determining the presence, absence or amount of two or more target polynucleotides in a sample comprising additional components, the method comprising: (i) contacting the sample with a panel of two or more probes under conditions suitable for hybridisation of the target polynucleotides to the probes, wherein: (a) each probe comprises a non-hybridisation region and a hybridisation region that specifically hybridises to one of the target polynucleotides to form a hybridised probe; and (b) the hybridisation region of a probe of the panel comprises one or more non-natural nucleotides; (ii) contacting the sample prepared in step (i) with a transmembrane pore through which a single stranded polynucleotide but not a double stranded polynucleotide can pass and applying a potential difference to the transmembrane pore such that the hybridised probes in the sample interact with the pore; (iii) measuring current blockades having a duration within a defined window, wherein: (a) the one or more non-natural nucleotides present in the hybridisation region of the probe increase or decrease the duration of the current blockade due to the probe hybridised to its target polynucleotide such that the proportion of current blockades that occur within the window due to the interaction of the hybridised probes with the pore is increased compared to when the corresponding one or more natural nucleotides are present in the hybridisation region; and (b) each hybridised probe gives rise to a current blockade indicative of that probe; and (iv) correlating the measured current blockades with the probes, thereby determining the presence, absence or amount of the two or more target polynucleotides in the sample. L'invention concerne un procédé permettant de déterminer la présence, l'absence ou la quantité de deux polynucléotides cibles ou plus dans un échantillon comprenant d'autres composants, le procédé comprenant : (i) la mise en contact de l'échantillon avec un panel de deux sondes ou plus dans des conditions induisant l'hybridation des polynucléotides cibles aux sondes, où : (a) chaque sonde comporte une région de non-hybridation et une région d'hybridation qui s'hybride spécifiquement à l'un des polynucléotides cibles pour former une sonde hybridée ; et (b) la région d'hybridation d'une sonde du panel comprend un ou plusieurs nucléotides non naturels ; (ii) la mise en contact de l'échantillon préparé à l'étape (i) avec un pore transmembranaire par lequel un polynucléoti